Find clinical trials for Melanoma in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Indianapolis, IN, USA:
Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin...
Phase 2
Indianapolis, Indiana, United States and 56 other locations
This is a Phase 1b/2, multi-center, open label umbrella study of patients ≥12 years of age with recurrent, progressive, or refractory melanoma...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 19 other locations
drug.There are 2 parts in this trial. In one part, participants have melanoma that has come back after treatment or can't be removed by surg...
Phase 2
Indianapolis, Indiana, United States and 28 other locations
Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood ca...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 13 other locations
KB707-01 is a Phase 1, open-label, multicenter, dose escalation and expansion study to evaluate the safety and tolerability of KB707 in adults with l...
Phase 1
Indianapolis, Indiana, United States and 13 other locations
A first-in-human, Phase I, open-label, multicenter study of WTX-124 administered as monotherapy and in combination with pembrolizumab to patients wit...
Phase 1
Indianapolis, Indiana, United States and 7 other locations
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...
Phase 1
Indianapolis, Indiana, United States and 39 other locations
This is a Phase 1, First-in-Human (FIH), open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, phar...
Phase 1
Indianapolis, Indiana, United States and 5 other locations
This is an open-label, multi-center, single arm, Phase II study to evaluate the efficacy and safety of T-DXd for the treatment of unresectable and/or...
Phase 2
Muncie, Indiana, United States and 29 other locations
This is a Phase 1/2A study of GV20-0251 being developed for the treatment of participants with advanced solid tumors, who are refractory to approved...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 12 other locations
Clinical trials
Research sites
Resources
Legal